James J. Burns & Company’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

James J. Burns & Company’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,241	Closed	-$167K	–	159
2025 Q1	$167K	Buy	5,241 +436	+9%	+$16.5K	0.03%	141
2024 Q4	$186K	Buy	4,805 +232	+5%	+$9.75K	0.03%	143
2024 Q3	$207K	Buy	4,573 +259	+6%	+$11.6K	0.04%	138
2024 Q2	$181K	Buy	+4,314	New	+$180K	0.04%	126
2024 Q1	–	Sell	-4,620	Closed	-$214K	–	94
2023 Q4	$214K	Buy	4,620 +1,212	+36%	+$49.4K	0.05%	114
2023 Q3	$138K	Sell	3,408 -77	-2%	-$3.51K	0.04%	103
2023 Q2	$169K	Buy	3,485 +279	+9%	+$14K	0.04%	111
2023 Q1	$158K	Buy	+3,206	New	+$165K	0.04%	111

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

James J. Burns & Company's GNOM Position: Q2 2025 in Review

James J. Burns & Company sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2025, closing a stake of 5,241 shares — an estimated $167K sold.

James J. Burns & Company first reported a position in GNOM in Q1 2023 and held it in 8 quarters. The position peaked at $214K in Q4 2023. 51 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.

James J. Burns & Company reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
James J. Burns & Company sold 5,241 Global X Genomics & Biotechnology ETF shares in Q2 2025, an estimated $167K.
James J. Burns & Company first reported a position in Global X Genomics & Biotechnology ETF in Q1 2023 and held it in 8 quarters.
James J. Burns & Company's Global X Genomics & Biotechnology ETF position peaked at $214K in Q4 2023.
51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.

Based on James J. Burns & Company's 13F filing for Q2 2025, filed 15 Jul 2025.